129 related articles for article (PubMed ID: 31848809)
1. Hypofractionated Radiation Therapy: A Potential Option for Advanced Intrahepatic Cholangiocarcinoma.
Shindoh J
Ann Surg Oncol; 2020 Apr; 27(4):983-984. PubMed ID: 31848809
[No Abstract] [Full Text] [Related]
2. Hypofractionated Radiation Therapy for Unresectable/Locally Recurrent Intrahepatic Cholangiocarcinoma.
Smart AC; Goyal L; Horick N; Petkovska N; Zhu AX; Ferrone CR; Tanabe KK; Allen JN; Drapek LC; Qadan M; Murphy JE; Eyler CE; Ryan DP; Hong TS; Wo JY
Ann Surg Oncol; 2020 Apr; 27(4):1122-1129. PubMed ID: 31873931
[TBL] [Abstract][Full Text] [Related]
3. Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
Hong TS; Wo JY; Yeap BY; Ben-Josef E; McDonnell EI; Blaszkowsky LS; Kwak EL; Allen JN; Clark JW; Goyal L; Murphy JE; Javle MM; Wolfgang JA; Drapek LC; Arellano RS; Mamon HJ; Mullen JT; Yoon SS; Tanabe KK; Ferrone CR; Ryan DP; DeLaney TF; Crane CH; Zhu AX
J Clin Oncol; 2016 Feb; 34(5):460-8. PubMed ID: 26668346
[TBL] [Abstract][Full Text] [Related]
4. Evidence-based integration of selective internal radiation therapy into the management of cholangiocarcinoma.
Fartoux L; Rosmorduc O
Future Oncol; 2014 Nov; 10(15 Suppl):89-92. PubMed ID: 25478776
[No Abstract] [Full Text] [Related]
5. Proton radiotherapy for primary liver cancers.
Granovetter M
Lancet Oncol; 2016 Feb; 17(2):e49. PubMed ID: 26723084
[No Abstract] [Full Text] [Related]
6. Proton Beam Therapy in Liver Malignancies.
Siddiqui O; Pollock A; Samanta S; Kaiser A; Molitoris JK
Curr Oncol Rep; 2020 Feb; 22(3):30. PubMed ID: 32108284
[TBL] [Abstract][Full Text] [Related]
7. Proton beam therapy for unresectable intrahepatic cholangiocarcinoma.
Ohkawa A; Mizumoto M; Ishikawa H; Abei M; Fukuda K; Hashimoto T; Sakae T; Tsuboi K; Okumura T; Sakurai H
J Gastroenterol Hepatol; 2015 May; 30(5):957-63. PubMed ID: 25376272
[TBL] [Abstract][Full Text] [Related]
8. Clinical Outcomes of Patients With Unresectable Cholangiocarcinoma Treated With Proton Beam Therapy.
Hung SP; Huang BS; Hsieh CE; Lee CH; Tsang NM; Chang JT; Chen JS; Chou WC; Tseng JH; Hong JH
Am J Clin Oncol; 2020 Mar; 43(3):180-186. PubMed ID: 31764017
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes of previously untreated patients with unresectable intrahepatic cholangiocarcinoma following proton beam therapy.
Shimizu S; Okumura T; Oshiro Y; Fukumitsu N; Fukuda K; Ishige K; Hasegawa N; Numajiri H; Murofushi K; Ohnishi K; Mizumoto M; Nonaka T; Ishikawa H; Sakurai H
Radiat Oncol; 2019 Dec; 14(1):241. PubMed ID: 31881895
[TBL] [Abstract][Full Text] [Related]
10. Treatment Selection and Survival Outcomes With and Without Radiation for Unresectable, Localized Intrahepatic Cholangiocarcinoma.
Jackson MW; Amini A; Jones BL; Rusthoven CG; Schefter TE; Goodman KA
Cancer J; 2016; 22(4):237-42. PubMed ID: 27441741
[TBL] [Abstract][Full Text] [Related]
11. Radiofrequency ablation of intrahepatic cholangiocarcinoma: feasability, local tumor control, and long-term outcome.
Butros SR; Shenoy-Bhangle A; Mueller PR; Arellano RS
Clin Imaging; 2014; 38(4):490-494. PubMed ID: 24637151
[TBL] [Abstract][Full Text] [Related]
12. Initial Results of Hypofractionated Carbon Ion Radiotherapy for Cholangiocarcinoma.
Abe T; Shibuya K; Koyama Y; Okamoto M; Kiyohara H; Katoh H; Shimada H; Kuwano H; Ohno T; Nakano T
Anticancer Res; 2016 Jun; 36(6):2955-60. PubMed ID: 27272810
[TBL] [Abstract][Full Text] [Related]
13. Chest wall toxicity after hypofractionated proton beam therapy for liver malignancies.
Yeung R; Bowen SR; Chapman TR; MacLennan GT; Apisarnthanarax S
Pract Radiat Oncol; 2018; 8(4):287-293. PubMed ID: 29452863
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic body radiotherapy dose and its impact on local control and overall survival of patients for locally advanced intrahepatic and extrahepatic cholangiocarcinoma.
Brunner TB; Blanck O; Lewitzki V; Abbasi-Senger N; Momm F; Riesterer O; Duma MN; Wachter S; Baus W; Gerum S; Guckenberger M; Gkika E
Radiother Oncol; 2019 Mar; 132():42-47. PubMed ID: 30825968
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma.
Gkika E; Hallauer L; Kirste S; Adebahr S; Bartl N; Neeff HP; Fritsch R; Brass V; Nestle U; Grosu AL; Brunner TB
BMC Cancer; 2017 Nov; 17(1):781. PubMed ID: 29162055
[TBL] [Abstract][Full Text] [Related]
16. Unresectable hilar cholangiocarcinoma: multimodality treatment with percutaneous and intraluminal plus external radiotherapy.
Golfieri R; Giampalma E; Fusco F; Galuppi A; Faccioli L; Galaverni C; Frezza G
J Chemother; 2004 Nov; 16 Suppl 5():55-7. PubMed ID: 15675480
[TBL] [Abstract][Full Text] [Related]
17. Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival.
Pitt HA; Nakeeb A; Abrams RA; Coleman J; Piantadosi S; Yeo CJ; Lillemore KD; Cameron JL
Ann Surg; 1995 Jun; 221(6):788-97; discussion 797-8. PubMed ID: 7794082
[TBL] [Abstract][Full Text] [Related]
18. Yttrium-90 microsphere radioembolization in unresectable intrahepatic cholangiocarcinoma.
Mosconi C; Cappelli A; Ascanio S; Pettinari I; Modestino F; Renzulli M; Galaverni MC; Cucchetti A; Gramenzi A; Pettinato C; Golfieri R
Future Oncol; 2017 Jun; 13(15):1301-1310. PubMed ID: 28343412
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of radiation therapy after surgery for hilar cholangiocarcinoma.
Sagawa N; Kondo S; Morikawa T; Okushiba S; Katoh H
Surg Today; 2005; 35(7):548-52. PubMed ID: 15976951
[TBL] [Abstract][Full Text] [Related]
20. Proton beam therapy for tumors of the upper abdomen.
Raldow A; Lamb J; Hong T
Br J Radiol; 2020 Mar; 93(1107):20190226. PubMed ID: 31430202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
